Concepedia

Alton B. Kremer

AB

12

Publications

2K

Citations

12

H-Index

1987

Active since

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Janssen (United States)

University of California, San Francisco

NewYork–Presbyterian Hospital

Cornell University

Alton B. Kremer is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, urology, and radiation oncology.

Top concepts

Publications per year

1987–2015

12

Publications

12

Lenvatinib, everolimus, and the combination in patients with metastatic renal cell carcinoma: a randomised, phase 2, open-label, multicentre trial

Robert J. Motzer, Thomas E. Hutson, Hilary Glen et al. · The Lancet Oncology · 2015 · 929 citations

, , +4

Phase I and Pharmacokinetic Study of Farnesyl Protein Transferase Inhibitor R115777 in Advanced Cancer

J. Zujewski, Ivan D. Horak, C.J. Bol et al. · Journal of Clinical Oncology · 2000 · 265 citations

Prognostic Significance of Extent of Disease in Bone in Patients With Androgen-Independent Prostate Cancer

Paul Sabbatini, Steven M. Larson, Alton B. Kremer et al. · Journal of Clinical Oncology · 1999 · 234 citations

Post-therapy Serum Prostate-Specific Antigen Level and Survival in Patients With Androgen-Independent Prostate Cancer

Howard I. Scher, W.M. Kelly, Zuo‐Feng Zhang et al. · JNCI Journal of the National Cancer Institute · 1999 · 166 citations · Full text

Antiviral Activity of Single‐Dose PRO 140, a CCR5 Monoclonal Antibody, in HIV‐Infected Adults

Jeffrey M. Jacobson, Michael S. Saag, Melanie Thompson et al. · The Journal of Infectious Diseases · 2008 · 112 citations · Full text

Rows per page

1–5 of 12